フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Insert as subheadline: NOT FOR DISTRIBUTION TO U.S...
ZYUS Life Sciences Corporation (“ZYUS” or the “Company”) (TSXV: ZYUS) is pleased to announce that Brent Zettl, President and CEO of ZYUS, will...
ZYUS Receives Patent from United States Patent and Trademark Office (“USPTO”) Supporting ZYUS’ Lead Drug Candidate ZYUS Life Sciences Corporation...
Dr. Clarke Joins ZYUS’ Clinical Advisory Committee, Bringing Extensive Expertise in Healthcare and Pain Management ZYUS Life Sciences Corporation...
Scott Livingstone brings extensive healthcare expertise and strategic leadership to ZYUS’ experienced team ZYUS Life Sciences Corporation (the...
Evaluating Efficacy, Safety, and Tolerability in Patients with Moderate to Severe Cancer-Related Pain ZYUS Life Sciences Corporation ("ZYUS" or...
Completion of Phase 1 and Supportive Preclinical Data Will Assist in Ongoing Phase 2 Clinical Development of ZYUS’ Lead Drug Product Candidate...
Mr. Miller brings nearly two decades of knowledge, experience and expertise to ZYUS ZYUS Life Sciences Corporation ("ZYUS" or the “Company”...
ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and...
Mr. Brownlee brings more than 30 years of knowledge, experience and expertise to ZYUS’ Board of Directors ZYUS Life Sciences Corp. ("ZYUS" or the...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約